Skip to Main Navigation
BRIEF

World Bank Group’s Operational Response to COVID-19 (coronavirus) – Projects List

Covid19 Vaccine

The World Bank Group is taking broad, fast action to help developing countries strengthen their pandemic response, increase disease surveillance, improve public health interventions, and help the private sector continue to operate and sustain jobs. At the forefront of the multilateral crisis response, the WBG delivered an unprecedented $204 billion in financial support to public and private sector clients in the first two calendar years of the crisis (CY20-21), of which $135 billion is from IBRD/IDA, $60 billion from IFC and $9 billion from MIGA.

As of June 30, 2022, the World Bank approved operations to support vaccine rollout in 78 countries amounting to $10.1 billion.  Through this, the World Bank Group is working with partners on the largest vaccination effort in history to stop the COVID-19 pandemic.

On April 2, 2020 the first group of projects using the dedicated COVID-19 Fast-Track Facility (also called the COVID-19 Strategic Preparedness and Response Program (SPRP)), amounting to $1.9 billion and assisting 25 countries, was rolled out.

On May 19, 2020 the Bank Group announced its emergency operations to fight COVID-19 have reached 100 developing countries – home to 70% of the world’s population. On October 13, 2020, $12 billion was approved for developing countries to finance the purchase and distribution of COVID-19 vaccines, tests, and treatments for their citizens. 

On June 30, 2021 President Malpass announced the expansion of financing available for COVID-19 vaccine financing to $20 billion over the next 18 months, adding $8 billion to the previously announced $12 billion.

In addition, we are working worldwide to redeploy resources in existing World Bank financed projects, including through restructuring and use of projects’ emergency components as well as contingent financing instruments designed for catastrophes, including pandemics.

 The lists below include:

  • Projects that are supported by the COVID-19 Fast-Track Facility, including support for COVID vaccine acquisition and/or deployment;

  • Projects with support from IBRD and IDA, with components responding to COVID-19, and projects that receive COVID-19 funding through restructuring, redeployment, and reallocation of existing resources.

These lists are updated as projects are processed and approved.

Projects that are supported by the COVID-19 Fast-Track Facility (including support for vaccines)

 
Africa

BeninAdditional financing for vaccines

Burkina Faso
Burundi, Additional financing
Cabo Verde, Additional financing for vaccinesThird additional financing for vaccines
Cameroon, Additional financing for vaccines
Central African Republic, Additional financing for vaccines
ChadAdditional financing for vaccines
Comoros Additional financing for vaccines
Côte d’Ivoire, Additional financing for vaccines
Democratic Republic of CongoAdditional financing for vaccines
Eswatini, Additional financing for vaccines
EthiopiaAdditional financing for vaccines, Second additional financing, Third additional financing
Gabon, Additional financing for vaccines
The Gambia, Second additional financing for vaccines, Third additional financing 
GhanaAdditional financing, Additional financing for vaccines
GuineaAdditional financing for vaccines
Guinea Bissau, Additional financing
KenyaAdditional financing for vaccines

LesothoAdditional financing for vaccines
Liberia, Additional financing for vaccines
Madagascar for vaccines, Additional financing
Malawi, Additional financing for vaccines
MaliAdditional financing for vaccines
Mauritania, Additional financing for vaccines, Second additional financing
Mozambique, Additional financing for vaccines

NigerAdditional financing for vaccines
Nigeria, Additional financing for vaccines
Republic of the CongoAdditional financing for vaccines
RwandaAdditional financing, Second additional financing for vaccines
Sao Tome e PrincipeAdditional financing for vaccines
Senegal
Sierra Leone, Additional financing for vaccines, Second additional financing for vaccines
Somalia
South Africa
South Sudan Additional financing for vaccines
Togo, Additional financing for vaccines, Second additional financing
Uganda, Additional financing for vaccines
ZambiaAdditional financing for vaccines
Zimbabwe
 

East Asia and Pacific
CambodiaAdditional financingAdditional financing for vaccines
Fiji
IndonesiaAdditional financing for vaccines
Kiribati
Lao PDR, Additional financing for vaccines
Marshall Islands
MongoliaAdditional financing for vaccines  
MyanmarAdditional financing
Papua New GuineaAdditional financing for vaccines
PhilippinesAdditional financing for vaccines, Second additional financing
Samoa
Solomon Islands
Timor-Leste
Europe and Central Asia
Albania
Belarus
Bosnia and Herzegovina
Georgia, Additional financing for vaccines
Kosovo, Additional financing for vaccines
Kyrgyz Republic
MoldovaAdditional financing for vaccines
North Macedonia
Serbia
TajikistanAdditional financingAdditional Financing and RestructuringAdditional financing for vaccines
Türkiye, Additional financing
Ukraine, Additional financing
UzbekistanAdditional financing
Latin America and the Caribbean 
Argentina, Additional financing for vaccines
Belize
Costa Rica
Ecuador, Additional financing for vaccines (Spanish)
El Salvador, Additional financing for vaccines (Spanish)
Guatemala
GuyanaAdditional financing for vaccines
Haiti, Additional financing for vaccines
Honduras, Additional financing for vaccines (Spanish)
Nicaragua
Panama, Additional financing for vaccines
Paraguay
Peru
Trinidad and Tobago
Uruguay 
Middle East and North Africa 
Djibouti
Egypt
Iran
Iraq
JordanAdditional financing for vaccines
Tunisia, Additional financing for vaccines
YemenAdditional financing for vaccines
South Asia 
AfghanistanAdditional financing for vaccines
BangladeshAdditional financing for vaccines
Bhutan
India
Maldives
NepalAdditional financing for vaccines
Pakistan
Sri LankaAdditional financing, Second additional financing for vaccines, Third additional financing for vaccines




Projects with support from IBRD and IDA, with components responding to COVID-19 and projects with other forms of finance/redeploying of existing projects

  
Africa 

Angola 

Benin

Burkina Faso


Burundi

Cabo Verde

Cameroon

Central African Republic

Chad

Comoros 

Congo, Republic of

Congo, Democratic Republic of

Eastern Africa

Eswatini 

Ethiopia

The Gambia

Ghana 

Guinea

Guinea-Bissau

Kenya

Liberia

  • Regional Disease Surveillance Systems Enhancement Project (REDISSE)
  • REDISSE Phase II

Madagascar

Malawi 

Mali 

Mauritania 

Mozambique

Niger

 

Nigeria

Rwanda

São Tomé and Príncipe 

Senegal

Seychelles 

Sierra Leone

Somalia

South Sudan

Sudan

Tanzania

Togo

Uganda

Western Africa

Zambia

East Asia and Pacific 

Cambodia 

China

Federated States of Micronesia 

Fiji 

Indonesia

Kiribati

Lao PDR 

Marshall Islands

Mongolia 

Myanmar 

Philippines

Samoa 

Solomon Islands

Tonga

Tuvalu

Vanuatu 

Vietnam

Europe and Central Asia

Albania

Bosnia and Herzegovina

Central Asia

Croatia

Georgia  

Kyrgyz Republic

North Macedonia

Turkey

Ukraine

Uzbekistan

Latin America and the Caribbean 

Argentina 

Bahamas

Belize 

Bolivia 

Brazil

Colombia

Costa Rica 

Dominica 

Dominican Republic

Ecuador

Grenada 

Guatemala

Guyana

Haiti

Honduras

Jamaica

Mexico

Nicaragua

Panama

Peru

Saint Lucia

Saint Vincent and the Grenadines 

Suriname 

Uruguay

Middle East and North Africa 

Djibouti

Egypt, Arab Republic of

Iraq 

Jordan

Lebanon 

Morocco

Tunisia 

West Bank and Gaza 

Yemen 

South Asia 

Afghanistan 

Bangladesh 

Bhutan

India 

Maldives 

Nepal 

Pakistan 

Sri Lanka  (press release for projects below)